Literature DB >> 19448187

Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia.

Melissa Fisher1, Christine Holland, Michael M Merzenich, Sophia Vinogradov.   

Abstract

OBJECTIVE: Impaired verbal memory in schizophrenia is a key rate-limiting factor for functional outcome, does not respond to currently available medications, and shows only modest improvement after conventional behavioral remediation. The authors investigated an innovative approach to the remediation of verbal memory in schizophrenia, based on principles derived from the basic neuroscience of learning-induced neuroplasticity. The authors report interim findings in this ongoing study.
METHOD: Fifty-five clinically stable schizophrenia subjects were randomly assigned to either 50 hours of computerized auditory training or a control condition using computer games. Those receiving auditory training engaged in daily computerized exercises that placed implicit, increasing demands on auditory perception through progressively more difficult auditory-verbal working memory and verbal learning tasks.
RESULTS: Relative to the control group, subjects who received active training showed significant gains in global cognition, verbal working memory, and verbal learning and memory. They also showed reliable and significant improvement in auditory psychophysical performance; this improvement was significantly correlated with gains in verbal working memory and global cognition.
CONCLUSIONS: Intensive training in early auditory processes and auditory-verbal learning results in substantial gains in verbal cognitive processes relevant to psychosocial functioning in schizophrenia. These gains may be due to a training method that addresses the early perceptual impairments in the illness, that exploits intact mechanisms of repetitive practice in schizophrenia, and that uses an intensive, adaptive training approach.

Entities:  

Mesh:

Year:  2009        PMID: 19448187      PMCID: PMC2720319          DOI: 10.1176/appi.ajp.2009.08050757

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  36 in total

1.  Development of an abbreviated schizophrenia quality of life scale using a new method.

Authors:  Warren B Bilker; Colleen Brensinger; Matthew M Kurtz; Christian Kohler; Ruben C Gur; Steven J Siegel; Raquel E Gur
Journal:  Neuropsychopharmacology       Date:  2002-10-17       Impact factor: 7.853

Review 2.  A review of cognitive training in schizophrenia.

Authors:  Elizabeth W Twamley; Dilip V Jeste; Alan S Bellack
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

3.  Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later.

Authors:  Melissa Fisher; Christine Holland; Karuna Subramaniam; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

Review 4.  Cortical plasticity: from synapses to maps.

Authors:  D V Buonomano; M M Merzenich
Journal:  Annu Rev Neurosci       Date:  1998       Impact factor: 12.449

5.  Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.

Authors:  B E Wexler; M Anderson; R K Fulbright; J C Gore
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

6.  Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.

Authors:  Sylvie Chouinard; Emmanuel Stip; Julie Poulin; Jean-Pierre Melun; Roger Godbout; François Guillem; Henri Cohen
Journal:  Curr Med Res Opin       Date:  2007-03       Impact factor: 2.580

7.  Associated deficits in mismatch negativity generation and tone matching in schizophrenia.

Authors:  D C Javitt; A Shelley; W Ritter
Journal:  Clin Neurophysiol       Date:  2000-10       Impact factor: 3.708

8.  A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.

Authors:  Donald C Goff; J Steven Lamberti; Andrew C Leon; Michael F Green; Alexander L Miller; Jayendra Patel; Theo Manschreck; Oliver Freudenreich; Steven A Johnson
Journal:  Neuropsychopharmacology       Date:  2007-05-09       Impact factor: 7.853

9.  The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

Authors:  Richard S E Keefe; Terry E Goldberg; Philip D Harvey; James M Gold; Margaret P Poe; Leigh Coughenour
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

10.  Temporal modeling demonstrates preserved overlearning processes in schizophrenia: an fMRI study.

Authors:  K Koch; G Wagner; I Nenadic; C Schachtzabel; M Roebel; C Schultz; M Axer; J R Reichenbach; H Sauer; R G M Schlösser
Journal:  Neuroscience       Date:  2007-04-19       Impact factor: 3.590

View more
  168 in total

Review 1.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Brain Res Bull       Date:  2010-04-24       Impact factor: 4.077

2.  Neural changes associated with relational learning in schizophrenia.

Authors:  Laura M Rowland; Jacqueline A Griego; Elena A Spieker; Carlos R Cortes; Henry H Holcomb
Journal:  Schizophr Bull       Date:  2010-04-23       Impact factor: 9.306

Review 3.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

Review 4.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

5.  Placebo Response and Practice Effects in Schizophrenia Cognition Trials.

Authors:  Richard S E Keefe; Vicki G Davis; Philip D Harvey; Alexandra S Atkins; George M Haig; Owen Hagino; Stephen Marder; Dana C Hilt; Daniel Umbricht
Journal:  JAMA Psychiatry       Date:  2017-08-01       Impact factor: 21.596

6.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 7.  Biomarkers in psychosis: an approach to early identification and individualized treatment.

Authors:  Heline Mirzakhanian; Fiza Singh; Kristin S Cadenhead
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 8.  Designing Serious Game Interventions for Individuals with Autism.

Authors:  Elisabeth M Whyte; Joshua M Smyth; K Suzanne Scherf
Journal:  J Autism Dev Disord       Date:  2015-12

9.  Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches.

Authors:  Keith H Nuechterlein; Joseph Ventura; Kenneth L Subotnik; Jacqueline N Hayata; Alice Medalia; Morris D Bell
Journal:  Am J Psychiatr Rehabil       Date:  2014-07

10.  Cognitive remediation: a new generation of psychosocial interventions for people with schizophrenia.

Authors:  Shaun M Eack
Journal:  Soc Work       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.